Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 29 | 2024 | 2640 | 3.900 |
Why?
|
Geriatric Assessment | 20 | 2024 | 1405 | 2.260 |
Why?
|
Frail Elderly | 17 | 2024 | 747 | 1.760 |
Why?
|
Peptidylprolyl Isomerase | 4 | 2015 | 97 | 1.380 |
Why?
|
Hematologic Neoplasms | 10 | 2023 | 1899 | 1.170 |
Why?
|
Patient Care Management | 2 | 2021 | 303 | 1.120 |
Why?
|
Alzheimer Disease | 14 | 2019 | 8551 | 0.990 |
Why?
|
Neoplasms | 23 | 2023 | 22066 | 0.960 |
Why?
|
Pharmacists | 3 | 2021 | 259 | 0.890 |
Why?
|
Aftercare | 3 | 2023 | 919 | 0.760 |
Why?
|
Geriatrics | 3 | 2022 | 385 | 0.750 |
Why?
|
Aged | 79 | 2024 | 169002 | 0.690 |
Why?
|
Neurodegenerative Diseases | 3 | 2022 | 1084 | 0.670 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2023 | 3333 | 0.650 |
Why?
|
Multiple Myeloma | 5 | 2024 | 5131 | 0.650 |
Why?
|
Parkinson Disease | 7 | 2014 | 2853 | 0.640 |
Why?
|
Aged, 80 and over | 41 | 2024 | 58953 | 0.600 |
Why?
|
Rehabilitation | 1 | 2019 | 129 | 0.600 |
Why?
|
Aging | 8 | 2023 | 8641 | 0.580 |
Why?
|
Hand Strength | 1 | 2019 | 452 | 0.530 |
Why?
|
Hospice Care | 1 | 2023 | 692 | 0.530 |
Why?
|
Sulfonylurea Compounds | 1 | 2017 | 221 | 0.520 |
Why?
|
Cardiovascular Diseases | 10 | 2024 | 15739 | 0.510 |
Why?
|
Dementia | 4 | 2024 | 2638 | 0.490 |
Why?
|
Pharmaceutical Services | 1 | 2016 | 141 | 0.490 |
Why?
|
Diagnostic Self Evaluation | 1 | 2016 | 225 | 0.480 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2018 | 321 | 0.460 |
Why?
|
Gait | 1 | 2019 | 812 | 0.450 |
Why?
|
Humans | 112 | 2024 | 760276 | 0.430 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 934 | 0.430 |
Why?
|
Proportional Hazards Models | 11 | 2020 | 12531 | 0.420 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2022 | 2282 | 0.420 |
Why?
|
Patient Discharge | 5 | 2023 | 3476 | 0.410 |
Why?
|
Physicians | 4 | 2022 | 4590 | 0.410 |
Why?
|
United States Department of Veterans Affairs | 6 | 2024 | 917 | 0.380 |
Why?
|
Clinical Coding | 1 | 2012 | 181 | 0.360 |
Why?
|
Parkinson Disease, Secondary | 1 | 2011 | 122 | 0.360 |
Why?
|
Comorbidity | 9 | 2023 | 10553 | 0.360 |
Why?
|
Stroke | 3 | 2023 | 9946 | 0.350 |
Why?
|
Selection, Genetic | 1 | 2015 | 872 | 0.350 |
Why?
|
Sexual Harassment | 2 | 2021 | 80 | 0.350 |
Why?
|
Patients | 1 | 2016 | 906 | 0.340 |
Why?
|
Metformin | 1 | 2017 | 912 | 0.340 |
Why?
|
Defibrillators, Implantable | 1 | 2019 | 1499 | 0.340 |
Why?
|
Male | 58 | 2024 | 359427 | 0.330 |
Why?
|
Age Factors | 9 | 2019 | 18416 | 0.330 |
Why?
|
Cardiology | 1 | 2021 | 1723 | 0.330 |
Why?
|
Cohort Studies | 18 | 2023 | 41316 | 0.320 |
Why?
|
Smoking | 6 | 2012 | 9070 | 0.310 |
Why?
|
Aspirin | 4 | 2021 | 3365 | 0.310 |
Why?
|
Risk Factors | 22 | 2024 | 74278 | 0.300 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2823 | 0.300 |
Why?
|
United States | 24 | 2024 | 72369 | 0.290 |
Why?
|
Endometrial Neoplasms | 1 | 2017 | 1361 | 0.290 |
Why?
|
Hospitals, Veterans | 5 | 2024 | 398 | 0.290 |
Why?
|
Prospective Studies | 18 | 2024 | 54265 | 0.280 |
Why?
|
Energy Metabolism | 2 | 2019 | 2869 | 0.280 |
Why?
|
Quality of Life | 3 | 2021 | 13301 | 0.270 |
Why?
|
Models, Neurological | 1 | 2015 | 1758 | 0.270 |
Why?
|
Quality Improvement | 5 | 2024 | 3840 | 0.270 |
Why?
|
Sickness Impact Profile | 1 | 2007 | 298 | 0.260 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1401 | 0.250 |
Why?
|
Female | 42 | 2024 | 391024 | 0.240 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3149 | 0.240 |
Why?
|
Kaplan-Meier Estimate | 4 | 2019 | 6546 | 0.230 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3223 | 0.230 |
Why?
|
Marital Status | 3 | 2023 | 432 | 0.230 |
Why?
|
Neurons | 4 | 2018 | 9417 | 0.220 |
Why?
|
Telemedicine | 2 | 2022 | 3004 | 0.220 |
Why?
|
Confidence Intervals | 3 | 2017 | 2932 | 0.220 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2023 | 3606 | 0.220 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3613 | 0.210 |
Why?
|
Risk Adjustment | 2 | 2021 | 601 | 0.210 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15828 | 0.200 |
Why?
|
Retrospective Studies | 14 | 2023 | 80311 | 0.200 |
Why?
|
Nurse's Role | 1 | 2023 | 188 | 0.200 |
Why?
|
Health Status | 2 | 2017 | 4084 | 0.200 |
Why?
|
Nerve Degeneration | 2 | 2018 | 748 | 0.190 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12602 | 0.190 |
Why?
|
Neuropsychology | 1 | 2022 | 107 | 0.190 |
Why?
|
Neoplasm Staging | 3 | 2024 | 11141 | 0.190 |
Why?
|
tau Proteins | 3 | 2017 | 2095 | 0.190 |
Why?
|
Myocardial Infarction | 3 | 2022 | 11894 | 0.190 |
Why?
|
Social Participation | 1 | 2022 | 183 | 0.180 |
Why?
|
Helping Behavior | 1 | 2020 | 21 | 0.180 |
Why?
|
Patient Identification Systems | 1 | 2020 | 75 | 0.180 |
Why?
|
Mitochondria | 1 | 2013 | 3598 | 0.180 |
Why?
|
Middle Aged | 27 | 2024 | 220179 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2017 | 15765 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2017 | 12280 | 0.170 |
Why?
|
Amyloid | 2 | 2015 | 843 | 0.170 |
Why?
|
Hospitalization | 5 | 2023 | 10761 | 0.170 |
Why?
|
Population Dynamics | 1 | 2021 | 306 | 0.160 |
Why?
|
Medication Reconciliation | 1 | 2021 | 151 | 0.160 |
Why?
|
Anorexia Nervosa | 2 | 2019 | 1361 | 0.160 |
Why?
|
Self Report | 2 | 2024 | 3707 | 0.160 |
Why?
|
Long-Term Care | 1 | 2023 | 628 | 0.160 |
Why?
|
Workflow | 2 | 2021 | 851 | 0.160 |
Why?
|
Prognosis | 9 | 2023 | 29640 | 0.160 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5797 | 0.160 |
Why?
|
Electronic Health Records | 5 | 2024 | 4762 | 0.160 |
Why?
|
Knowledge Bases | 1 | 2019 | 98 | 0.160 |
Why?
|
Survival Analysis | 4 | 2018 | 10185 | 0.150 |
Why?
|
Age Distribution | 3 | 2009 | 2893 | 0.150 |
Why?
|
Ambulatory Care Facilities | 2 | 2022 | 926 | 0.150 |
Why?
|
Incidence | 8 | 2017 | 21379 | 0.150 |
Why?
|
Acetaminophen | 1 | 2022 | 553 | 0.150 |
Why?
|
beta Carotene | 2 | 2010 | 524 | 0.150 |
Why?
|
Patient Care Planning | 1 | 2023 | 909 | 0.150 |
Why?
|
Patient Participation | 1 | 2007 | 1437 | 0.150 |
Why?
|
Mass Screening | 2 | 2016 | 5422 | 0.140 |
Why?
|
Maine | 1 | 2016 | 144 | 0.140 |
Why?
|
Heart Failure | 2 | 2019 | 11836 | 0.130 |
Why?
|
Dexamethasone | 1 | 2023 | 1927 | 0.130 |
Why?
|
Quantitative Trait, Heritable | 1 | 2019 | 540 | 0.130 |
Why?
|
International Classification of Diseases | 1 | 2021 | 884 | 0.130 |
Why?
|
Signal Transduction | 2 | 2018 | 23366 | 0.130 |
Why?
|
Natural Language Processing | 1 | 2024 | 1136 | 0.130 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39256 | 0.130 |
Why?
|
Program Evaluation | 3 | 2021 | 2494 | 0.120 |
Why?
|
Chronic Disease | 1 | 2010 | 9287 | 0.120 |
Why?
|
Epidemiologic Factors | 1 | 2014 | 36 | 0.120 |
Why?
|
Review Literature as Topic | 1 | 2017 | 350 | 0.120 |
Why?
|
Accidental Falls | 1 | 2022 | 1054 | 0.120 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2023 | 4547 | 0.120 |
Why?
|
Risk Assessment | 7 | 2024 | 24086 | 0.120 |
Why?
|
Brain Injuries | 2 | 2017 | 2044 | 0.120 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2022 | 3695 | 0.120 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2024 | 1076 | 0.120 |
Why?
|
Case-Control Studies | 5 | 2022 | 22040 | 0.120 |
Why?
|
Occupational Health | 1 | 2020 | 804 | 0.110 |
Why?
|
Patient Selection | 2 | 2021 | 4276 | 0.110 |
Why?
|
Life Style | 3 | 2018 | 3888 | 0.110 |
Why?
|
Professional Role | 1 | 2016 | 311 | 0.110 |
Why?
|
Stochastic Processes | 1 | 2015 | 354 | 0.110 |
Why?
|
Thermodynamics | 1 | 2015 | 599 | 0.110 |
Why?
|
New England | 2 | 2015 | 1045 | 0.110 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 732 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1605 | 0.110 |
Why?
|
SEER Program | 1 | 2018 | 1532 | 0.110 |
Why?
|
Hyperlipidemias | 1 | 2018 | 782 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2020 | 1826 | 0.100 |
Why?
|
Central Nervous System Diseases | 1 | 2017 | 521 | 0.100 |
Why?
|
Adult | 17 | 2023 | 219843 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2022 | 5201 | 0.100 |
Why?
|
Proline | 1 | 2014 | 457 | 0.100 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 409 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1899 | 0.100 |
Why?
|
Tauopathies | 1 | 2015 | 317 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1534 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 951 | 0.100 |
Why?
|
Cognition | 2 | 2021 | 6948 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1572 | 0.090 |
Why?
|
Survival Rate | 3 | 2019 | 12806 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1532 | 0.090 |
Why?
|
Cause of Death | 2 | 2020 | 3723 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2019 | 10343 | 0.090 |
Why?
|
Activities of Daily Living | 4 | 2023 | 2414 | 0.090 |
Why?
|
Disabled Persons | 1 | 2020 | 1226 | 0.090 |
Why?
|
Diabetes Mellitus | 3 | 2018 | 5884 | 0.090 |
Why?
|
Odds Ratio | 3 | 2017 | 9714 | 0.090 |
Why?
|
Life Expectancy | 1 | 2016 | 1249 | 0.080 |
Why?
|
Animals | 8 | 2018 | 167935 | 0.080 |
Why?
|
Primary Health Care | 2 | 2023 | 4649 | 0.080 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2014 | 1110 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2508 | 0.080 |
Why?
|
Neuropsychological Tests | 4 | 2023 | 7016 | 0.070 |
Why?
|
Hospitals | 1 | 2021 | 3930 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6856 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3310 | 0.070 |
Why?
|
Algorithms | 2 | 2024 | 13959 | 0.070 |
Why?
|
Software | 1 | 2020 | 4419 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15272 | 0.070 |
Why?
|
Family | 1 | 2017 | 3189 | 0.070 |
Why?
|
Protein Conformation | 1 | 2014 | 3969 | 0.070 |
Why?
|
Rural Population | 1 | 2016 | 2267 | 0.060 |
Why?
|
Prevalence | 4 | 2019 | 15684 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3159 | 0.060 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 1109 | 0.060 |
Why?
|
Referral and Consultation | 3 | 2022 | 3598 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17766 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3329 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2018 | 3976 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2135 | 0.060 |
Why?
|
Models, Animal | 1 | 2010 | 2117 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2020 | 3524 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2008 | 12159 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13629 | 0.060 |
Why?
|
Delirium | 1 | 2015 | 1653 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4361 | 0.060 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14481 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2009 | 968 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5248 | 0.050 |
Why?
|
Institutionalization | 1 | 2023 | 105 | 0.050 |
Why?
|
Mortality | 2 | 2020 | 2916 | 0.050 |
Why?
|
Diabetic Angiopathies | 1 | 2008 | 822 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Coronary Disease | 1 | 2017 | 5993 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11708 | 0.050 |
Why?
|
England | 1 | 2024 | 526 | 0.050 |
Why?
|
State Medicine | 1 | 2024 | 213 | 0.050 |
Why?
|
Cell Cycle | 1 | 2010 | 2936 | 0.050 |
Why?
|
Behavioral Symptoms | 1 | 2024 | 186 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4900 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10439 | 0.050 |
Why?
|
Coronary Artery Bypass | 2 | 2023 | 2274 | 0.050 |
Why?
|
Retirement | 1 | 2023 | 199 | 0.050 |
Why?
|
Genome, Human | 1 | 2015 | 4416 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8502 | 0.050 |
Why?
|
Databases, Factual | 1 | 2017 | 8022 | 0.050 |
Why?
|
Health Behavior | 2 | 2011 | 2621 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18135 | 0.050 |
Why?
|
Technology | 1 | 2023 | 292 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2017 | 64968 | 0.040 |
Why?
|
Phenotype | 2 | 2019 | 16543 | 0.040 |
Why?
|
Polypharmacy | 1 | 2022 | 307 | 0.040 |
Why?
|
Risk | 3 | 2019 | 9629 | 0.040 |
Why?
|
Policy | 1 | 2023 | 511 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 25927 | 0.040 |
Why?
|
Telephone | 1 | 2022 | 623 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2696 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5790 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5395 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 11902 | 0.040 |
Why?
|
Systems Integration | 1 | 2020 | 426 | 0.040 |
Why?
|
Veterans Health | 1 | 2020 | 216 | 0.040 |
Why?
|
Axons | 2 | 2017 | 1672 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9196 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6242 | 0.040 |
Why?
|
Sex Factors | 1 | 2012 | 10529 | 0.040 |
Why?
|
Attitude to Health | 1 | 2007 | 2028 | 0.040 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8595 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13249 | 0.040 |
Why?
|
Boston | 2 | 2020 | 9283 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 58673 | 0.030 |
Why?
|
Walking | 1 | 2023 | 1190 | 0.030 |
Why?
|
Independent Living | 1 | 2019 | 568 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2015 | 245 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 788 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2019 | 1344 | 0.030 |
Why?
|
Adolescent | 3 | 2017 | 87749 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1790 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2295 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2019 | 1996 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5324 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1765 | 0.030 |
Why?
|
Brain | 2 | 2017 | 26905 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1921 | 0.030 |
Why?
|
Fasting | 1 | 2019 | 1603 | 0.030 |
Why?
|
Recovery of Function | 1 | 2023 | 2983 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1375 | 0.020 |
Why?
|
Memory Disorders | 1 | 2019 | 1197 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2019 | 1880 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14655 | 0.020 |
Why?
|
Memory, Short-Term | 1 | 2018 | 977 | 0.020 |
Why?
|
Research Design | 2 | 2017 | 6181 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2321 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1759 | 0.020 |
Why?
|
Caregivers | 1 | 2023 | 2223 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2101 | 0.020 |
Why?
|
Patient Care Team | 1 | 2022 | 2510 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 12900 | 0.020 |
Why?
|
Hong Kong | 1 | 2010 | 161 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2010 | 295 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2010 | 314 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2717 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3924 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2010 | 871 | 0.020 |
Why?
|
Epitopes | 1 | 2015 | 2506 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5877 | 0.020 |
Why?
|
Drug Discovery | 1 | 2016 | 1056 | 0.020 |
Why?
|
Attention | 1 | 2019 | 2386 | 0.020 |
Why?
|
Melanoma | 1 | 2007 | 5694 | 0.020 |
Why?
|
Sleep | 1 | 2024 | 4744 | 0.020 |
Why?
|
Mice | 2 | 2015 | 81212 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2015 | 1395 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2017 | 1933 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8553 | 0.020 |
Why?
|
Motor Activity | 1 | 2017 | 2687 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 859 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2010 | 803 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8314 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6017 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2015 | 2441 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8805 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12412 | 0.020 |
Why?
|
Blood Glucose | 1 | 2019 | 6375 | 0.010 |
Why?
|
Insulin | 1 | 2019 | 6592 | 0.010 |
Why?
|
Palliative Care | 1 | 2019 | 3607 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3469 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6771 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3762 | 0.010 |
Why?
|
Transfection | 1 | 2010 | 5782 | 0.010 |
Why?
|
Women's Health | 1 | 2011 | 2057 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13315 | 0.010 |
Why?
|
Child | 2 | 2022 | 79759 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10758 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3442 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16908 | 0.010 |
Why?
|
Body Weight | 1 | 2011 | 4613 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6361 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8621 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2011 | 2064 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40141 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22026 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5784 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2011 | 4012 | 0.010 |
Why?
|
Computational Biology | 1 | 2010 | 3504 | 0.010 |
Why?
|
Genotype | 1 | 2010 | 12959 | 0.010 |
Why?
|
Exercise | 1 | 2011 | 5784 | 0.010 |
Why?
|
Diet | 1 | 2011 | 8008 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9590 | 0.010 |
Why?
|
Transcription Factors | 1 | 2010 | 12100 | 0.010 |
Why?
|